Patents by Inventor Jesus A. Diazgranados

Jesus A. Diazgranados has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of human diseases involving dysregulation or dysfunction of the nervous system
    Patent number: 5302583
    Abstract: A method of preventing, treating and/or controlling diseases caused by dysregulation and/or dysfunction of various portions of the nervous system which comprises administering to a patient, an effective amount of a compound of the avermectin family, e.g. ivermectin, in single or multiple doses of up to 1.6 mg/kg at intervals of from 3 days to 4 months.
    Type: Grant
    Filed: November 23, 1992
    Date of Patent: April 12, 1994
    Assignee: Fractal Laboratories, Inc.
    Inventors: Jonathan L. Costa, Jesus A. Diazgranados
  • Methods for increasing arousal and alertness and for the amelioration of comatose states
    Patent number: 5248678
    Abstract: A method of treating comatose patients or near-comatose patients to increase their arousal and alertness as measured by the Glascow Coma Score by administering effective amounts of an adenosine receptor antagonist and a GABA agonist, either concomitantly in any order including simultaneously, or by administering an adenosine receptor antagonist as the sole active agent. The methods of administration are intravenous bolus or drip injection, subcutaneous injection or orally.
    Type: Grant
    Filed: June 30, 1992
    Date of Patent: September 28, 1993
    Assignee: Fractal Laboratories, Inc.
    Inventors: Jonathan L. Costa, Hernan V. Salazar, Jesus A. Diazgranados
  • Treatment of human diseases involving dysregulation or dysfunction of the nervous system
    Patent number: 5189026
    Abstract: A method of preventing, treating and/or controlling diseases caused by dysregulation and/or dysfunction of various portions of the nervous system which comprises administering to a patient, an effective amount of a compound of the avermectin family, e.g. ivermectin, in single or multiple doses of up to 1.6 mg/kg at intervals of from 3 days to 4 months.
    Type: Grant
    Filed: June 7, 1991
    Date of Patent: February 23, 1993
    Assignee: Fractal Laboratories, Inc.
    Inventors: Jonathan L. Costa, Jesus A. Diazgranados